Market cap: $92,654,919
Exchange: NAS
Sector: Health Technology
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant, or MDR, bacterial infections. Its pipeline product candidates include SPR994, SPR741, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
Company Name
Spero Therapeutics Inc
Average Volume (10 days)
231,897
Average Volume (30 days)
521,265
Moving Average (50 days)
$1.64
Moving Average (200 days)
$1.36
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
0
Market Cap
92,654,919
Shares Outstanding
53,869,139
52-Week High Split Adjust Only
2
52-Week Low Split Adjust Only
0.99
Employee Count
0
Beta
0.963
Next Earnings Date
2024-05-09
TTM Dividend Rate Per Share
0
Past 5 days
-0.01%
Past 30 days
0.04%
Past 3 months
0.18%
Past 6 months
0.43%
Past year
0.27%
Past 2 years
-0.78%
Past 5 years
-0.86%
Max % Change
-0.11%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Spero Therapeutics Inc | SPRO | n/a | n/a | -5.0 | n/a | n/a |
| Peer Avg | N/A | 1.74 | 2.39 | 177.4 | 1.74 | 1.85 |
| International Business Machines Corp. | IBM | 1.74 | 6.00 | 13.2 | 1.74 | 2.35 |
| Thomson-Reuters Corp | TRI | 8.03 | 3.28 | 52.5 | 8.03 | 8.23 |
| DoubleVerify Holdings Inc | DV | n/a | n/a | 143.0 | n/a | n/a |
| Vita Coco Company Inc (The) | COCO | n/a | n/a | n/a | n/a | n/a |
| Franklin Covey Co. | FC | 2.40 | 7.43 | 1033.3 | 2.40 | 2.36 |